The Hidden Cost of Building Health Content In-House
Research Report by CARAVAN Wellness

Creating health content internally can appear less expensive than licensing or partnering with an external content provider. The comparison often begins with writing costs and ends too early.
High-quality health content requires more than a writer. It requires clinical expertise, editorial governance, accessibility, production, localization, technology, maintenance, and accountability across every format, language, and channel where the content appears.
The true question is not how much it costs to produce the first draft. It is how much it costs to maintain an accurate, accessible, current, and defensible content capability over time.
The Real Cost Extends Beyond Writing
A single article may require research, source verification, clinical review, editorial review, legal or compliance review, health-literacy testing, accessibility checks, metadata, publishing, analytics, and future updates.
Video adds scripting, expert selection, filming, production, editing, captions, transcripts, graphics, and version management. Interactive tools and assessments require additional clinical logic, user-experience design, development, testing, and data governance.
These activities are often distributed across clinical, legal, marketing, product, and technology teams. Because the work does not always appear within a dedicated content budget, the total cost can be difficult to see.
The work still consumes internal capacity. Every hour spent reviewing a script, validating a source, updating a translation, or correcting an accessibility issue is time that cannot be directed toward another clinical, product, or organizational priority.
A realistic build-versus-buy analysis should therefore calculate the cost of the maintained asset, not only the drafted one.
AI Changes the Cost Structure, Not the Accountability
Generative AI can accelerate ideation, research organization, outlining, summarization, reading-level adjustments, and preliminary drafting. It can reduce the time required to create an initial version.
It does not remove the need for qualified human review.
Health content must still be evaluated for clinical accuracy, evidence quality, sourcing, readability, tone, accessibility, audience fit, intellectual property, and consistency with current guidance.
Peer-reviewed research illustrates why source verification remains essential. A 2024 study comparing ChatGPT and Bard on systematic-review reference tasks found that 28.6% of references produced by GPT-4 and 91.4% of references produced by Bard were hallucinated. The study examined research-reference generation rather than patient-facing articles, so those percentages should not be interpreted as the error rate for all health content. They do demonstrate that an authoritative tone is not evidence of source accuracy.
The faster an initial draft is produced, the more important it becomes to verify every medical claim and supporting reference before publication.
Governance Often Lags AI Adoption
AI use has expanded faster than many organizations’ formal governance programs.
Teams need documented standards for acceptable uses, source verification, clinical review, privacy, intellectual property, bias, accessibility, version control, disclosure, and final approval. They also need clarity about which uses require additional legal or compliance oversight.
Without those controls, AI can introduce inconsistent quality across teams and increase rework later. A tool that saves time during drafting can still increase total cost if it creates additional clinical, legal, or reputational risk.
Ownership is another consideration. The U.S. Copyright Office has concluded that copyright protection requires sufficient human authorship and that prompts alone generally do not give the user enough control over an AI system’s expressive output to establish authorship. AI-assisted materials may still be protectable when meaningful human creativity is present, but that determination depends on the nature of the human contribution.
For organizations building proprietary health libraries, the workflow should document both the human review and the human creative contribution rather than treating raw AI output as finished intellectual property.
Scale Multiplies Complexity
Building a small set of content is different from maintaining a library across hundreds of conditions, audiences, formats, languages, and channels.
A clinical change to one foundational source may require corresponding revisions to an article, video, infographic, audio file, quiz, assessment, translated version, caption file, transcript, metadata record, portal page, and mobile experience.
Each variation becomes another maintained asset with its own review history, location, version, and update requirement.
At scale, organizations need a content-management system, taxonomy, managed terminology, review calendar, ownership model, archival process, and reliable method for distributing updates across products.
Without that infrastructure, teams may know that a source asset changed but still lack visibility into every derivative version that must also be corrected.
Multilingual Content Multiplies More Than Translation Cost
Multilingual health content can appear especially easy to create in-house. A team may assume it can translate an English article with AI, generate a handout in another language, and publish it within minutes.
That approach accounts for the initial translation, not the full operating requirement.
Healthcare translation involves more than replacing English words with their closest equivalents. Organizations must determine which languages their populations need, whether members prefer to speak and read in the same language, how medical terminology will be managed, and whether instructions remain clear, actionable, and appropriate for the intended audience.
AHRQ recommends using qualified translators, offering written and video materials in patients’ preferred languages, supporting multilingual portal experiences, and addressing language access across scheduling, clinical encounters, billing, follow-up communications, secure messaging, and patient feedback. It also distinguishes translation from interpretation because the two functions require different professional competencies.
AI may accelerate a first translation, but it does not confirm that the result is clinically accurate, written at an appropriate health-literacy level, culturally relevant, accessible, or fully aligned with the source material.
Each language version may still require qualified linguistic review, clinical or subject-matter review, accessibility testing, approval, and continuing maintenance.
The cost also compounds across formats. An organization maintaining 200 source topics in five languages is no longer maintaining 200 assets. Before accounting for video, audio, graphics, assessments, captions, or channel-specific versions, it may already be managing as many as 1,000 language-specific assets.
If those 200 topics are produced in four formats across five languages, the theoretical asset count increases to 4,000 maintained versions. Not every organization will use every possible combination, but the calculation illustrates why multilingual scale quickly becomes a content-operations challenge rather than a simple translation expense.
The National CLAS Standards include 15 action steps intended to help healthcare organizations provide culturally and linguistically appropriate services. They reinforce that language access requires governance, communication infrastructure, workforce capability, and accountability, not only translated documents.
For organizations supporting several languages across a large library, multilingual scale can become one of the strongest arguments for licensing foundational content or using a managed partner while retaining internal ownership of differentiated, organization-specific materials.
Accessibility Is a Standing Requirement
Accessibility cannot be added only at the end of production. It affects writing, design, video, audio, web development, and document structure from the beginning.
Captions, transcripts, screen-reader compatibility, alternative text, keyboard navigation, color contrast, readable layouts, and plain language all require expertise and quality assurance. Multilingual accessibility adds another layer because each language and format must remain accessible after translation or adaptation.
The federal Section 504 rule for recipients of HHS funding establishes WCAG 2.1 Level AA as the technical standard for covered web and mobile content. The requirement can apply across websites, mobile applications, portals, and telehealth experiences, including certain content delivered through third parties.
This matters to both build and buy decisions. Licensing content does not automatically make the purchasing organization compliant. The organization still needs to confirm that the content, integration, platform, and surrounding user experience meet its applicable obligations.
When accessibility is treated as a remediation task, organizations may pay twice: once to create and publish the content and again to revise the writing, design, code, video, or document after barriers are identified.
Health Literacy Creates Another Quality Requirement
Clinical accuracy does not guarantee patient understanding.
Medical terminology, long sentences, unclear action steps, and complex numerical information can make technically correct content difficult to use.
National health-literacy guidance generally recommends patient education at approximately a fifth- to sixth-grade reading level. Yet research continues to find that much patient-facing health information exceeds recommended readability levels.
A recent analysis of online patient education materials from high-impact medical journals found that approximately 90% were written at or above an eighth-grade level, with little evidence of improvement over two decades.
Readability formulas do not measure every aspect of comprehension, and reading level alone is not a complete quality standard. However, the gap illustrates why clinical review and health-literacy review should be treated as separate steps.
An internal team may need a clinician to confirm accuracy, an editor to simplify structure, and a health-literacy or user-experience specialist to confirm that the audience can identify what the information means and what action to take.
Maintenance Is a Permanent Cost
Health guidance changes. Clinical recommendations, medications, screening standards, regulations, benefits, and care pathways evolve over time.
A content library is only as trustworthy as its maintenance process.
Organizations need to know who owns each asset, when it was last reviewed, which sources support it, which derivative formats and translations depend on it, and where each version is currently published.
Content that is accurate at launch can become a liability when the evidence or guidance changes but the material remains available.
The cost of maintenance includes more than the final edit. Teams must monitor source changes, identify affected assets, complete clinical and editorial review, update translations and accessibility elements, publish revisions, archive older files, and communicate the change across internal or external distribution points.
That work repeats for the life of the library.
Quality Failures Create Rework and Trust Costs
Errors in health content can require urgent correction across several channels.
The direct cost may include clinical escalation, editing, legal review, production, translation, platform changes, redistribution, and customer communication. The broader cost may include delayed launches, interrupted implementations, reputational concerns, or reduced confidence in the organization’s content.
A single source error becomes more expensive as the number of formats, languages, and channels increases. Correcting one English article is different from correcting a clinical statement that also appears in translated videos, captions, graphics, quizzes, portal pages, and partner integrations.
These risks do not mean every organization should outsource content. They mean quality-failure costs should be included in the operating model rather than treated as an unlikely exception.
Build, Buy, or Blend
Some organizations have the internal expertise and infrastructure to build specialized content effectively. Others benefit from licensing a clinically governed library that can be customized and integrated into their products.
Many organizations use a blended model. They build proprietary materials where their clinical model, brand, or program design creates meaningful differentiation, while licensing high-volume foundational education that requires broad topic coverage, multilingual production, accessibility, and continuous maintenance.
The right model depends on strategic differentiation, required speed, internal capacity, update frequency, clinical risk, audience complexity, and the number of formats, languages, and channels that must be maintained.
A managed partner shifts recurring work and cost, but it does not eliminate organizational accountability. Buyers still need to evaluate clinical standards, accessibility, linguistic quality, update practices, integration requirements, and alignment with their own legal and compliance responsibilities.
A realistic evaluation should compare total cost of ownership, time to value, internal opportunity cost, quality controls, maintenance requirements, and risk.
The Big Takeaway
The hidden cost of in-house health content is not the writing. It is the operating system required to keep the content accurate, accessible, current, scalable, multilingual, and defensible.
AI can improve efficiency, but it shifts effort toward source verification, clinical review, copyright assessment, governance, and approval rather than eliminating those responsibilities.
Scale compounds the requirement. Every additional format, language, audience, and channel creates another version that may need review and updating throughout its useful life.
Organizations should evaluate build, buy, and blended models based on the full lifecycle of the content, not the price of producing the first draft.
The strongest approach builds what is strategically distinctive, partners for the high-volume foundational work that is difficult to maintain efficiently, and applies AI only within a governed workflow that keeps qualified people accountable for the final result.



